Robert K Liem1, Paul H Niloff. 1. Department of Surgery, JFK Medical Center, 5301 South Congress Avenue, Atlantis, FL33462, USA.
Abstract
BACKGROUND: There has been controversy regarding prophylactic cholecystectomy with Roux-en Y gastric bypass. The results reported in open cases showed no significant increase in morbidity by the addition of cholecystectomy. A series of open cases were reviewed to evaluate the propriety of prophylactic cholecystectomy. METHOD: The records of 141 patients undergoing cholecystectomy during open gastric bypass were reviewed, documenting age, ultrasound findings and pathology. RESULTS: Of the 141 cases analyzed, the incidence of gall-bladder pathology was 80%. 24 (17%) of the 141 patients were noted to have gallstones on preoperative ultrasound examination, and 3 (2%) showed polyps. 9 patients (6%) had gallstones at surgery with normal ultrasound. Cholesterolosis was present in 52 cases (37%) and chronic cholecystitis in 25 cases (18%). CONCLUSION: In view of the high incidence of gall-bladder disease (80%) already present in morbidity obese patients undergoing gastric bypass and the lack of significant morbidity in open surgery with prophylactic cholecystectomy, the addition of prophylactic cholecystectomy appears appropriate.
BACKGROUND: There has been controversy regarding prophylactic cholecystectomy with Roux-en Y gastric bypass. The results reported in open cases showed no significant increase in morbidity by the addition of cholecystectomy. A series of open cases were reviewed to evaluate the propriety of prophylactic cholecystectomy. METHOD: The records of 141 patients undergoing cholecystectomy during open gastric bypass were reviewed, documenting age, ultrasound findings and pathology. RESULTS: Of the 141 cases analyzed, the incidence of gall-bladder pathology was 80%. 24 (17%) of the 141 patients were noted to have gallstones on preoperative ultrasound examination, and 3 (2%) showed polyps. 9 patients (6%) had gallstones at surgery with normal ultrasound. Cholesterolosis was present in 52 cases (37%) and chronic cholecystitis in 25 cases (18%). CONCLUSION: In view of the high incidence of gall-bladder disease (80%) already present in morbidity obesepatients undergoing gastric bypass and the lack of significant morbidity in open surgery with prophylactic cholecystectomy, the addition of prophylactic cholecystectomy appears appropriate.
Authors: Michel Bastouly; Carlos Haruo Arasaki; Jael Brasil Ferreira; Arnaldo Zanoto; Fabíola Gouveia H P Borges; José Carlos Del Grande Journal: Obes Surg Date: 2008-08-12 Impact factor: 4.129
Authors: Anna C Weiss; Tazo Inui; Ralitza Parina; Alisa M Coker; Garth Jacobsen; Santiago Horgan; Mark Talamini; David C Chang; Bryan Sandler Journal: Surg Endosc Date: 2014-12-17 Impact factor: 4.584
Authors: Bernabé M Quesada; Gustavo Kohan; Hernán E Roff; Carlos M Canullán; Luis T Chiappetta Porras Journal: World J Gastroenterol Date: 2010-05-07 Impact factor: 5.742